TrialToxicological sciences : an official journal of the Society of Toxicology2024

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).

Kathleen M Scullion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.